RegisterLogin

C14-490

CAT: 0804-HY-165604Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-165604Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
C14-490, an ionizable cationic lipid (pKa = 5.94), is used for the synthesis of lipid nanoparticles (LNPs) . C14-490 LNPs is used as the basis for subsequent study of in utero gene editing in HSCs. C14-490 LNPs are used to encapsulate SpCas9 mRNA and TTR sgRNA using optimized B5 formulation parameters and surface conjugation to CD45 antibody F (ab’) 2 fragments-Systematically optimized Targeted Editing Machinery LNPs (STEM LNPs) [1].
CAS Number
[2639634-82-3]
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
OC(CCCCCCCCCCCC)CN(CC(CN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)OCC)CCN1CCN(CC(CN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)OCC)CC1
Molecular Formula
C86H177N5O7
Molecular Weight
1393.35
References & Citations
[1]Rohan Palanki, et al. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proc Natl Acad Sci U S A. 2024 Aug 6;121 (32) :e2400783121.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-124177-01C14 Ceramide
HY-152229-01G0-C14
HY-159853C14-A1
HY-W588183-01C14-Dihydroceramide
HY-148842-01C14-4
HY-159854-01C14-O2
HY-157923Trehalose C14
HY-160569-01C14-SPM
HY-159869-01G0-C14 analog
HY-172749IMCTA-C14 (TFA)

Alternative Products

CatalogName
TYD-01884-01C14-490
T75027-01G0-C14
TRC-C262830-5MGC14 Dihydroceramide
BA7869-10C14-4
267798-01C14-Ceramide
T84671-01C14-SPM
sc-210983C14 Ceramide
T201879-01C14-A1
T201881-01C14-O2
TSH-00094-01Trehalose C14

Popular Products